With a short percentage of shares outstanding of 3.21%, Zoetis Inc. (NYSE:ZTS) is among the 7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue.
On May 27, Argus downgraded Zoetis Inc. (NYSE:ZTS) from Buy to Hold following a sharp decline in the company’s share price
The research firm pointed to a steep 22% single-day drop in the stock, followed by additional weakness, as evidence of growing investor concerns about the company’s near-term growth trajectory. According to the analyst, the market reaction reflected diminishing confidence in Zoetis’ ability to sustain the level of expansion investors had previously expected, prompting a more cautious stance on the shares despite the company’s established position in the animal health industry. Earlier, on May 22, Stifel lowered its price target on Zoetis Inc. (NYSE:ZTS) to $95 from $105 while maintaining a Hold rating.
The firm acknowledged that the company’s updated 2026 guidance indicates business conditions could gradually improve over time, signaling management’s expectation for a recovery in operating performance as the year progresses. However, Stifel also noted that competitive pressures are likely to remain elevated across several key markets in the near term, creating challenges that could weigh on growth. Even so, the revised outlook suggests the company sees opportunities to strengthen its performance despite an increasingly competitive environment.